Advertisement
Advertisement
BLLN
BillionToOne, Inc. Class A Common Stock
113.94
USDSponsored
+1.55
+1.38%
Nov 06, 15:59 UTC -5
Closed
After-Market
113.89
-0.05
-0.04%
BillionToOne, Inc. Class A Common Stock (BLLN) Earnings
BLLN Earnings Reports
Positive Surprise Ratio
BLLN beat 3 of 5 last estimates.
60%
Next Report
Date of Next Report
Mar 02, 2027
Estimate for Q4 26 (Revenue/ EPS)
$123.93M
/$0.14
Implied change from Q3 26 (Revenue/ EPS)
+0.77%
/-56.25%
Implied change from Q4 25 (Revenue/ EPS)
+29.02%
/+27.27%
BillionToOne, Inc. Class A Common Stock earnings per share and revenue
On Nov 04, 2026, BLLN reported earnings of 0.32 USD per share (EPS) for Q3 26, beating the estimate of 0.14 USD, resulting in a 115.34% surprise. Revenue reached 122.98 million, compared to an expected 117.90 million, with a 4.31% difference. The market reacted with a -1.32% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.14 USD, with revenue projected to reach 123.93 million USD, implying an decrease of -56.25% EPS, and increase of 0.77% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.40
Surprise
+10.04%
ICU Medical Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.17
Actual
$2.44
Surprise
+11.93%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Trulieve Cannabis Corp.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.07
Actual
$0.09
Surprise
+26.05%
PERRIGO COMPANY PLC
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.50
Actual
$0.60
Surprise
+18.44%
LeMaitre Vascular, Inc.
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.70
Actual
$0.65
Surprise
-7.14%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.10%
Apyx Medical Corporation Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.04
Surprise
+57.98%
Nephros Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.05
Surprise
+110.08%
Accendra Health, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.01
Actual
-$0.23
Surprise
-2,177.23%
FAQ
What were BillionToOne, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, BillionToOne, Inc. Class A Common Stock reported EPS of $0.32, beating estimates by 115.34%, and revenue of $122.98M, 4.31% above expectations.
How did the market react to BillionToOne, Inc. Class A Common Stock's Q3 2026 earnings?
The stock price moved down -1.32%, changed from $113.89 before the earnings release to $112.39 the day after.
When is BillionToOne, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Mar 02, 2027.
What are the forecasts for BillionToOne, Inc. Class A Common Stock's next earnings report?
Based on --
analysts, BillionToOne, Inc. Class A Common Stock is expected to report EPS of $0.14 and revenue of $123.93M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.